Etanercept
Etanercept, a biologic. Dimeric fusion protein of the extracellular ligand-binding portion of TNFR2 (p75) linked to the Fc domain of… Subcutaneous half-life 2.8 d.
Dimeric fusion protein of the extracellular ligand-binding portion of TNFR2 (p75) linked to the Fc domain of human IgG1. Acts as a 'decoy receptor' binding both TNFα and lymphotoxin-α, neutralising them before they engage cell-surface receptors. Unlike anti-TNF mAbs, does NOT bind membrane-bound TNF effectively → ineffective in Crohn's disease (an important MOA distinction).
NOT an IgG monoclonal antibody — a dimeric p75 TNF-receptor Fc FUSION protein, and its kinetics differ from the antibody class accordingly: a half-life of about three days against two to four weeks for true antibodies, so no class default should ever be applied to it. mw 150000 is correct and label-supported ("934 amino acids ... apparent molecular weight of approximately 150 kilodaltons") and is deliberately left alone rather than harmonised to the generic 148000. PK: Zhou 2004 (PMID:15496641), a two-compartment population fit over 53 healthy subjects and 212 patients whose pooled data INCLUDE IV dosing, verbatim "volume of distribution in the central compartment (V(c): 5.97 +/- 0.45 L)" and "absolute bioavailability for subcutaneous administration (F: 0.626 +/- 0.056)" — taken together so volume and bioavailability come from one coherent fit. Half-life 68 h from Korth-Bradley 2000 (PMID:10676822), 26 healthy volunteers, 25 mg SC, verbatim "the half-life was 68 +/- 19 hours"; that is a one-compartment subcutaneous fit and so is partly absorption-limited. The stored 70 h was the floor of the cited review's "70 to 100 hours" range stored as a point, and the stored V of 7 L appears nowhere in that review, which states no volume at all. NOTE the 5.97 L is a CENTRAL volume, so a one-compartment curve built on it understates exposure duration. PK: ABSORPTION RATE AUTHORED FROM A VERBATIM PEAK TIME. This row carried no ka, so the solver substituted 1.0/h and the modelled peak landed at 4.6 h — for a slowly-absorbed subcutaneous product that is wrong by design, not by a little. Source: "Etanercept is absorbed slowly from the site of subcutaneous injection, with time to peak concentration at approximately 48 to 60 hours". RANGE: shorter endpoint taken. With the stored half-life fixing ke, Tmax solves uniquely for ka by inverting the model own definition, ln(ka/ke)/(ka-ke) = Tmax — ARITHMETIC, NOT AN ESTIMATE — giving 0.03712/h, which reproduces 48 h on substitution. EXPOSURE IS UNCHANGED: the absorption rate cancels out of AUC entirely, so only the shape moves.
Pharmacokinetics
- Subcutaneous — t½ 2.8 d · F 63% · ka 0.03712 h⁻¹ · Vd 5.97 L
Sources: PMID:15831771, PMID:20519961, PMID:15496641, PMID:10676822